Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Swedencare Summary
– An Animal Health care company with global presence in a fast growing market
– Sales in 50 countries, both with fully owned subsidiaries and external distributors
– ProDen PlaqueOff – a world leading product within oral care– complemented by a wide
range of nutraceuticals (NutriScience)
– Own production facility on Ireland with a wide product offering
– A fragmented market – continued expansion through acquisitions
– High growth and profitability
– Listed On NASDAQ First North since 14 June 2016
Company Timeline
2017 (March)
1990’s 2016 (January) 2016 (July) Production of
2001 2006 Swedencare acquire PlaqueOff in own
Research & discovery of Swedencare
Swedencare start Patents in former distributors in factory in Ireland
advantages of product acquire Biodistra
selling within the Nordic Europe and USA France, UK and USA
are registered AB
2015 2016 (November)
2000 2005 2016 (June)
New Business Swedencare acquire
Establishment of current International expansion Company is listed
Plan developed the Irish company
business of Swedencare in Europe is launched on Nasdaq First
with new owners NutriScience (Ecuphar
North
Ltd.)
DOG CAT HORSE
ACCESSORIES
NUTRACEUTICALS
FEED
PRESCRIBED
PRODUCTS
Headcount:
Swedencare and the World Swedencare AB: 6
Biodistra: 1
SDC Distribution: 1
Swedencare UK: 6
Swedencare Ireland: 12
Swedencare US: 4
Swedencare Buccosanté: 2
Pet market in China grows
Nutraceuticals, 2500
164 million pets in the by double digits. Both by
MUSD in Europe and
U.S. number of pets and
USA – Growth 10–15%
spending
per year
Strategy in three parts
Product Portfolio and
Distribution Marketing
Channels
PlaqueOff *B2C and B2B
5 Sales Offices
NutriScience Exhibitions
>25
New products *Distributor
distributors
support
Sales in 50
*Training
countries
*Digital
Vet
Pet retail
Pharmacies
Retail
Pets – from something you own to a member of the family – * 94% sees the pet as a family member – The pets live longer – age related symptoms increase – Increased demand for organic feed and nutraceuticals – Demand of premium products grows – *46% of the pet owners have bought a nutraceutical at least once *) USA
PlaqueOff – a leading oral
health product
– Systemic effect on Oral Health
– Patent- and Trade mark protected in all our major markets
– Several clinical studies
– Marketed in several sizes and forms – powder, Dental Bites, Dental Bone, in feed ( fall 2017)
– 1 250 000 pots – equates to the yearly consumption for 0,5 million dogs/cats ≈ 1,2% of all
registered dogs/cats in the USA, Europe, China and Japan
– Retail value, over 35 MUSD
Clinical Studies – VOHC The difference between the placebo product and the tested product (ProDen PlaqueOff®) was 30-70% P1 Placebo P2 ProDen PlaqueOff®
New products 2017 NutriScience by Swedencare for dogs and cats A new group of products within several focus areas for dogs and cats. o Joints and mobility o Skin and coat o Multivitamin supplement o Calming supplement NutriScience by Swedencare for horses We are expanding the selection and we are now able to offer products which also soothes and prevents common problems with horses. o Digestive supplement o For a healthy stomach o For strength and performance o Cooling gel o Salt replacement
H1 Main Events
– Integrate Swedencare Ireland and our extended organization in the UK and Sweden into our
global group
– Design and develop a Swedencare line of NutriScience-products for sales within the pet
health care group – Launch in Nordics Q3 2017
– Continue with focused marketing activities in Asia, especially in China and South Korea
– Launching of our new ”Dental Care Bones” in the US market with better than expected
demand – Launching in Europe Q3 2017
– ERP-system change in Ireland
– Preparation of launching of feed – Fall 2017Key Performance Indicators – H1
EBITDA
REVENUE SOLVENCY
10 544 Tkr
41 259 Tkr 25,6% 66,7 %
CHANGE IN NET INCOME
REVENUES
64 % 4 805 TkrRolling 4 Quarters - Sales
80 000
70 000 70 084
62 885
60 000
53 721
50 000
43 367
40 000
37 242
34 326
30 000
27 685 26 834
24 166 24 400 26 001
20 000
10 000
0
Q4 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 Q3 2016 Q4 2016 Q1 2017 Q2 2017Rolling 4 Quarters - EBITDA
18 000
17 089
16 000 16 480
14 000 14 046
12 000 12 005
11 225
10 000 9 792 10 315
8 654 8 805
8 000
6 868
6 000 6 161
4 000
2 000
0
Q4 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 Q3 2016 Q4 2016 Q1 2017 Q2 2017Sales per Product
Q2 2016 Q2 2017
Other Other
10% 5%
PlaqueOff
Dental
NutriScienc
Bites
e
15%
28%
PlaqueOff
Powder
47%
PlaqueOff
PlaqueOff
Dental
Powder
Bones
75% PlaqueOff Dental Bites
12%
9%Stock Trend Over Time Introduction price: 14 SEK
Owners 2017-06-30 Antal aktier ägarandel Håkan Svanberg & Co Health Care AB 5 170 982 32,79% Mastan AB (Håkan Lagerberg genom bolag) 2 202 352 13,96% JCC Group Invest Sweden AB (Johan Bergdahl genom bolag) 2 202 351 13,96% SEB Life International (Swedia Capital AB) 800 786 5,08% AMF Aktiefond Småbolag 755 000 4,79% Walker Crips Weddle Beck PLC 622 816 3,95% SHB Fonder 500 000 3,17% Avanza Pension 377 015 2,39% Timer Hill Europe AG (Martin Shimko - VD Swedencare USA) 333 714 2,12% ML, Pierce Fenner & Smith Inc. 222 173 1,41% BNP PARIBAS (Hans Persson - VD Swedencare Frankrike) 199 750 1,27% KBC Securities (Ecuphar NV) 195 122 1,24% Tedcap AB (Thomas Eklund genom bolag) 190 000 1,20% Nordnet Pensionsförsäkring AB 169 343 1,07% Grandeur, Fund BBHBOS 158 855 1,01% Lin Micka 150 772 0,96% Staffan Johansson 135 277 0,86% Per Malmström Consulting AB 120 000 0,76% Anders Lönner 109 066 0,69% Granit Fonder Småbolag 100 000 0,63% Övriga 1 055 248 6,69% Totalt 15 770 622 100,00%
Priorities in H2 • Dental Care Bones • Expanding NutriScience range • China launch • Co-ops with feed partners • Review acquisition opportunities • Digital presence and marketing support • Further strengthen partnerships with major players in Vet- and Pet Specialty retailers
Financial Strategy long term
Sales Forecast Trend
250
200
150
100
Budget 2017: 80M
H1 2017 Rolling 4 Qrts: 70M
50
0
2015 2016 2017 2018 2019 2020Why invest in/choose – Interesting market segment – Growing market with high potential – Well known trademark – Unique worldwide distribution network – Significant growth & impressive margins – Strong interest from institutional investors
You can also read
